Psychosocial Support Reducing the Cost of Cancer

Video Library - Video
Victoria Kennedy, LCSW
According to Vicki Kennedy, early research indicates that psychosocial support can provide cost-savings by reducing hospital readmissions, decreased emergency department visits, and better utilization of staff. There are many groups doing research to determine the cost-effectiveness of these new patient standards.
Related Items
Questions About Treating Patients Using a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
Hope S. Rugo, MD
Conference Correspondent  published on December 9, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Matthew P. Goetz, MD
Conference Correspondent  published on December 8, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Hot Topics at SABCS 2017
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
HER2+ Breast Cancer and CDK4/6 Inhibitors
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Last modified: February 9, 2017